TGFB1 and breast cancer: As breast cancers progress to reach more advanced stages, they secrete higher levels of TGFβ and several chemokines that recruit the N2 subtype, which also respond to IL-10, thereby promoting tumor cell survival, metastasis and angiogenesis.